Work

Healthcare Utilization and Imputed Costs of Acute Myeloid Leukemia Patients By FLT3 Status and Early Midostaurin Use at a Comprehensive Cancer Center

Year: 2018

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2018-99-113479

Authors: Minkyoung Yoo, Jyothi Menon, Connor Willis, Sudhir Unni, Trang Au, Joseph Biskupiak, Briana Ndife, George J Joseph, Gaetano J Bonifacio, Eytan M. Stein, Srinivas K. Tantravahi, Paul J. Shami, Tibor Kovacsovics, Diana Brixner, David Dean Stenehjem

Institutions: University of Utah, Novartis (United States), Memorial Sloan Kettering Cancer Center, Huntsman Cancer Institute

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2980929602

Cites:

Cited by:

Related to: 10